Skip to main content
OpenTrials

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,195 public trials 541 recruiting studies
Refine in advanced search Browse all conditions

Communicable Diseases trial results

Recruiting

A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed

NCT07650916

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Los Angeles, California, United States
View all 88 locations
View Trial Details
Recruiting

Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy

NCT07682961

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • CAN Community Health Fort Lauderdale Fort Lauderdale, Florida, United States
  • Midway Immunology and Research Center Ft. Pierce, Florida, United States
  • Be Well Medical Center Berkley, Michigan, United States
  • Optimus Medical Group San Francisco, California, United States
View all 19 locations
View Trial Details
Recruiting

National Liver Cancer Screening Trial

NCT06084234

Conditions
Adenocarcinoma, Blood-Borne Infections, Carcinoma, +22 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Stanford University Redwood City, California, United States
  • Kaiser Permanente Roseville, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 19 locations
View Trial Details
Recruiting

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

NCT05592626

Conditions
Abdominal Neoplasm, Abdominal Neoplasms, Adenocarcinoma, +91 more
Locations
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • AdventHealth Celebration Celebration, Florida, United States
  • University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • The University of Kansas Cancer Center Kansas City, Kansas, United States
View all 19 locations
View Trial Details
Recruiting

PopSci CHW4CervixHealth

NCT07336134

Conditions
Cervical Cancer, Communicable Diseases, DNA Virus Infections, +25 more
Locations
  • Thomas Jefferson University Philadelphia, Pennsylvania, United States
View Trial Details
Recruiting

The Australian HCV Point-of-Care Testing Program

NCT05042544

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Hepatitis ACT Canberra, Australian Capital Territory, Australia
  • Western NSW LHD Bathurst, New South Wales, Australia
  • Far West LHD Broken Hill, New South Wales, Australia
  • Maari Ma Health Aboriginal Corporation Broken Hill, New South Wales, Australia
View all 69 locations
View Trial Details

Related conditions